Caspase 8 is a cysteine protease that initiates apoptotic signaling via the extrinsic pathway in a manner dependent upon association with early endosomes. Previously, we identified caspase 8 as an effector of migration, promoting motility in a manner dependent upon phosphorylation on Tyr-380 by Src family kinases and its subsequent association with Src homology 2 domain-containing proteins. Here we demonstrate the regulation of the small GTPase Rab5, which mediates early endosome formation, homotypic fusion, and maturation by caspase 8. Regulation requires the Tyr-380 phosphorylation site but not caspase proteolytic activity. Tyr-380 is essential for interaction with the Src homology 2 domains of p85␣, a multifunctional adaptor for phosphatidylinositol 3-kinase, that possesses Rab-GAP activity. Interaction between caspase 8 and p85␣ promotes Rab5 GTP loading, alters endosomal trafficking, and results in the accumulation of Rab5-positive endosomes at the edge of the cell. Conversely, caspase 8-dependent GTP loading of Rab5 is overcome by increased expression of p85␣ in a Rab-GAPdependent manner. Thus, we demonstrate a novel function for caspase 8 as a modulator of p85␣ Rab-GAP activity and endosomal trafficking.
Santa Cruz Biotechnology. Polyclonal anti-EEA1 (catalog #ab50313) and polyclonal anti-M6PR (catalog #ab32815) antibodies were from Abcam (Cambridge, MA). Goat anti-rabbit and goat anti-mouse antibodies coupled to horseradish peroxidase (HRP) and monoclonal anti-actin antibody (catalog #A5316) were from Bio-Rad. Alexa Fluor 488-and Alexa Fluor 555-labeled secondary antibodies, Alexa Fluor 488-labeled transferrin (catalog #T13342), BODIPY FL low density lipoprotein (LDL; catalog #L3483), and TO-PRO-3 (catalog #T3605) were from Molecular Probes (Eugene, OR). The FuGENE 6 Transfection Reagent was from Roche Diagnostics. The PureLink TM Quick Plasmid Miniprep (catalog #K2100-10) and PureLink TM Hipure Plasmid Filter Purification (catalog #K2100-17) kits were from Invitrogen. Geneticin (G418 sulfate, catalog #11811) was from Invitrogen. Cell medium and antibiotics were from Cellgro TM Mediatech, Inc (Herndon, VA). Fetal bovine serum (catalog #SH30070.03) was from HyClone (Logan, UT). Peroxidase from HRP and the peroxidase substrate 2,2Ј azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) were from Sigma. Glutathione-Sepharose TM 4B was from GE Healthcare. Chemiluminescent substrate (catalog #34078) and protein A/G beads were from Pierce. Protease inhibitors mixture tablets were from Roche Diagnostics.
Cell Culture-293T and A549 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics (10,000 units/ml penicillin, 10 g/ml streptomycin) at 37°C, 5% CO 2 . The previously described human neuroblastoma cells NB7 and NB7C8 were cultured in RPMI with 10% fetal bovine serum and antibiotics (20) . Lentiviral-mediated down-regulation of caspase 8 in A549 cells by short hairpin RNA was previously described (25) . Stably transfected cells were maintained in presence of 400 g of puromycin. For transient transfection experiments in HEK293T, NB7, and NB7C8 cells, the reagent FuGENE was used following the instructions provided by the manufacturer.
Plasmids-Rab5 mutants were described elsewhere (26) . Wild type Rab5 and the mutants Rab5/S34N and Rab5/Q79L were subcloned from pET3C vector (a kind gift from Dr. S. Schmid, the Scripps Research Institute) into pcDNA3.1(ϩ) by PCR using the primers 5Ј-cgggatccatggctaatcgaggagcaaca-3Ј and 5Ј-cccgcggccgcttagttactacaacactgact-3Ј and the restriction sites BamHI/NotI. The previously described "Rab5 binding domain" comprising the last 73 amino acids of Rabaptin-5 (residues 789 -862) was obtained by PCR using human Rabaptin5 cloned into pCMV-SPORT6 (Invitrogen) as a template and the primers 5Ј-cccgcggccgctcatgtctcaggaagctggt-3Јand 5Ј-cggtcgacaagctaaggctaccgttgaaca-3Ј. The PCR product was digested and ligated into pGEX-6P1 (GE Healthcare) by using the restriction sites SalI/NotI. Human caspase 8 was available in the pcDNA3.1(ϩ) and pEGFP-N2 vectors, as previously described (13, 19) . The caspase 8 mutants C360A and Y380F were previously reported and cloned into pEGFP-N2 vector (13) . Bovine FLAG-tagged wild type p85␣, p85␣/R274A (mutant defective for Rab-GAP activity), and p85␣/R368A/R649A (double mutant ⌬R, defective in both SH2 domains via point mutations) were previously described (8) .
Immunofluorescence-Cells were grown for 24 h on glass coverslips and subjected or not to treatment as indicated. After rinsing with PBS, cells were fixed in PBS, 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100 (5 min), and blocked with 2% BSA in PBS (30 min) at room temperature. Cells were then incubated with either monoclonal anti-Rab5 IgG (1:50), polyclonal anti-Rab7 IgG (1:50), polyclonal anti-M6PR IgG (1:50), or polyclonal anti-EEA1 (1:250) primary antibodies followed by incubation with the respective Alexa Fluor conjugated secondary antibodies (1:250). Nuclei were stained with TO-PRO-3 (1:500). Samples were then washed and mounted onto slides with the Vectashield Hard-Set mounting media (Vector Laboratories, Burlingame, VT) and visualized on a Nikon Eclipse C1 confocal microscope with a 1.4 NA 60ϫ oil immersion lens using minimum pinhole (30 m). Images were captured using EZ-C1 3.50 imaging software and analyzed using National Institutes of Health ImageJ software.
Image Analysis; Measurement of the Incidence of Cells with Peripheral Rab5-Pictures were randomly chosen, and cells were comparatively defined as "positive for periphery Rab5 staining" or "negative for periphery Rab5 staining" based on the high or low relative staining for Rab5 at cell periphery. Then the percentage of "positive cells" was calculated with respect to the total cell number. Total cell number was counted by nuclear staining (ToPRO3). For quantification of peripheral Rab5, pictures were randomly chosen, and round-shaped cells were picked for individual analysis. Cell periphery was defined as the area between the cell surface and 2-3 m beneath (in cells ranging between 20 and 25 m in diameter). This area corresponds to the ϳ25% outer layer of the cell. Relative levels of Rab5 were calculated within this area by using the "Radial Profile Plugin" of the ImageJ software. A total of six cells per picture, five pictures per experiment in a total of three independent experiments was analyzed. For analysis, the red channel (Rab5 staining) was adjusted to a window/level of 160 pixels, and then a radial profile was drawn around the cell (outer circle). The integrated density of pixels was measured within this outer circle. Thereafter, a second radial profile (inner circle) was drawn with a radius of 3/4 of the outer circle. The integrated density of pixels was measured within this inner circle. Finally, an arbitrary estimation of the percentage of peripheral Rab5 was calculated as % peripheral Rab5 ϭ 100 Ϫ (no. of pixels inner circle/no. of pixels outer circle).
Co-localization Analysis-ImageJ software was used for analysis. First, both red and green channels to be analyzed were adjusted to a window/level of 160 pixels, and the integrated intensity of pixels for each channel was measured. Thereafter, the integrated intensity of pixels co-localized was measured by using the "Co-localization RGB Plugin" of ImageJ.
Immunoblotting-Cell extracts were prepared in radioimmune precipitation assay buffer (100 mM Tris base, 150 mM NaCl, 1 mM EDTA, 1% deoxycholic acid, 1% Triton X-100, 0.1% SDS, 50 mM NaF) containing protease inhibitors, boiled in Laemmli buffer, and separated by SDS-PAGE on 10 or 12% acrylamide minigels (Bio-Rad) by loading 25 g of total protein per lane and transferred to nitrocellulose. Blots were blocked with 5% milk in 0.1% Tween, PBS and then probed with anti-actin (1:5000), anti-Rab5 (1:500), anti-Rab7 (1:300), anti-EEA1 (1:1000), or anti-M6PR (1:2500) antibodies. Bound antibodies were detected with horseradish peroxidase-conjugated secondary antibodies and the ECL system.
Transient Transfections-Cells were grown for 24 h in complete medium at 50 -70% confluence. Transfections were performed with 10 g of the indicated plasmids by using the FuGENE system according to the manufacturer's instructions. Post-transfection, extracts were obtained and subjected to either immunoprecipitation or pulldown analysis.
Immunoprecipitation-Cell extracts were prepared in a buffer containing 20 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, and protease inhibitors. Supernatants obtained after centrifugation (13,000 ϫ g, 5 min, 4°C) were used for immunoprecipitation assays (500 g of total protein per assay) with protein A/G beads-immobilized antibody. Caspase 8 was immunoprecipitated with mouse monoclonal anti-caspase 8. The immunoprecipitated samples were solubilized in Laemmli buffer, boiled, and separated by SDS-PAGE and analyzed by Western blotting as indicated above.
GTP-loaded Rab5 Pulldown Assay-The Rab5 pulldown assay was performed as previously described (27, 28) with some modifications. After treatment, cell extracts were prepared in lysis buffer containing 25 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 1% Nonidet P-40, 10% glycerol, 1 mM dithiothreitol, and protease inhibitors. Extracts were incubated by 5 min on ice and clarified by centrifugation (10,000 ϫ g, 1 min, 4°C). Postnuclear supernatants were used immediately for pulldown assays by adding 150 g of precoated beads. GSH beads were precoated with 100 g of GST-R5BD by 1 h at 4°C. Pulldown incubations were carried out by 15 min in a rotating shaker at 4°C. Thereafter, beads were collected and washed 3 times with lysis buffer containing 0.01% Nonidet P-40 and protease inhibitors. Samples were solubilized in Laemmli buffer, boiled, and separated by SDS-PAGE and analyzed by Western blotting as indicated above.
Endosome Fractionation in Sucrose Gradients-Endosome fractionation and HRP uptake assays were performed as previously described (29, 30) . Briefly, cells were grown in 15-cm plates for 24 h in complete medium. Cell monolayers were washed in PBS and incubated at 37°C with 5 ml of 2 mg/ml HRP in minimal essential medium supplemented with 10 mM glucose and 10 mM HEPES, pH 7.4 (internalization medium), at the indicated times. Incubations were stopped on ice by washing cells thoroughly with PBS at 4°C. Cells were scraped, collected by centrifugation at 1500 rpm at 4°C for 5 min in a Sorvall RT 6000D centrifuge. Cells were then washed with 10 ml of icecold PBS, centrifuged at 1700 rpm at 4°C for 5 min and finally resuspended in homogenization buffer (250 mM sucrose, 1 mM EDTA, 3 mM imidazole, pH 7.4), centrifuged at 2000 rpm at 4°C for 10 min. The cell pellet was resuspended in 500 l of homogenization buffer containing protease inhibitors and homogenized by 8 passages through a 22 1 ⁄ 2-gauge needle in a 1-ml syringe (BD Biosciences). Post-nuclear supernatants were obtained by centrifuging homogenates 10 min at 3000 rpm at 4°C in a bench Eppendorf centrifuge. The post-nuclear supernatants (PNS) was brought to 40.6% sucrose by mixing 400 l of PNS with 600 l of 60% sucrose in homogenization buffer buffer. A gradient was prepared by overlaying 1 ml of homogenate, 40.6% sucrose, 2 ml of 35% sucrose, 1.5 ml of 30% sucrose, 400 l homogenization buffer (8% sucrose) in a SW55Ti centrifuge tube. The gradient was centrifuged at 36,000 rpm (125,000 ϫ g) for 66 min at 4°C in a Beckman L7-65 ultracentrifuge. Endosome fractions were collected as follows; early endosomes at the 30/35% sucrose interface and late endosomes at the 8/30% sucrose interface. For protein screening, 45 l of each fraction was mixed with sample buffer and loaded onto 10% acrylamide minigels. To measure the relative amount of endocytosed HRP and the distribution in endosome fractions, 2-10 l of each fraction was incubated with 2,2Ј azino-bis(3ethylbenzthiazoline-6-sulfonic acid) (Sigma) and read at 405 nm according to the manufacturer's protocol.
LDL and Transferrin Internalization and Recycling Assays-NB7 and NB7C8 cells were grown at confluence in complete medium for 24 h. Thereafter, cells were detached with trypsin, centrifuged, re-suspended with 0.2% BSA in minimal essential medium supplemented with 10 mM glucose, 10 mM HEPES, pH 7.4 (internalization medium), and incubated for 30 min at 37°C. For internalization experiments, 250 l of aliquots of cell suspensions (5 ϫ 10 5 cells) were placed in 1000-l test tubes. Cells were centrifuged and resuspended with 0.2% BSA in internalization medium containing either 30 g/l Alexa Fluor 488-labeled transferrin or 5 g/l BODIPY FL LDL at 4°C. Incubations were carried out at 37°C and stopped on ice at different time points as indicated. Thereafter, cells were washed with ice-cold PBS, fixed with 0.5% paraformaldehyde, and resuspended with 2% BSA in PBS. For recycling experiments, cells were incubated with 30 g/l of Alexa Fluor 488-labeled transferrin as indicated above for 15 min. Then samples were immediately placed in ice, washed with ice-cold PBS, re-suspended with 0.2% BSA in internalization medium, and incubated at different times at 37°C. Cells were then collected, washed, and fixed as indicated above. Samples were analyzed by fluorescence-activated cell sorter (FACSCalibur) using the CellQuest Pro software.
Statistical Analysis-Where pertinent, results were compared using unpaired t tests of at least three independent experiments or as indicated. A p value Ͻ0.05 was considered significant.
RESULTS

Caspase 8 Induces Accumulation of Rab5 Endosomes at Cell
Periphery-Emerging evidence suggests that caspase 8 influences cellular adhesion and migration (22) likely via activation of Rac at the cell periphery (15, 16) . Interestingly, Rac function is spatially regulated by the endocytic protein Rab5 during cell migration (23) . To explore this potential link between caspase 8 and endocytic machinery, we first evaluated the cellular distribution of several endocytic markers in cells expressing or deficient for caspase 8. To this end we used the previously reported neuroblastoma cells NB7, which lack endogenous caspase 8 and those stably reconstituted for "physiological" levels of caspase 8 (i.e. higher expression than NB5 but lower than NB16) (19, 20) . We assessed the distribution of early endosomal markers (EEA1 and Rab5) and late endosomal or lysosomal proteins (Rab7 and the cation-independent mannose-6 phosphate receptor (M6PR)) in this model. Interestingly, the localization of Rab5 differed in cells expressing caspase 8 relative to caspase Rab5 Regulation by Caspase 8 8 -deficient cells, with accumulation of Rab5 in the cell periphery ( Fig. 1A ). This altered distribution was selective to Rab5, with no changes in expression or distribution of EEA1, Rab7, and M6PR (data not shown), suggesting that at physiological levels of expression caspase 8 did not influence all aspects of the endocytic pathway. We were unable to determine whether overexpression of caspase 8 could further augment this effect or could induce changes to secondary endosomal pathways, as overexpression of caspase 8 induces apoptosis (data not shown).
In neuroblastoma cells lacking caspase 8, Rab5 was homogenously distributed throughout the cell body, with a minor accumulation at the cell periphery ( Fig. 1, A and B) . The accumulation of Rab5 at the cell periphery was dependent upon expression of caspase 8, as suppression of caspase 8 with short hairpin RNA ablated the accumulation of Rab5 in the periphery (Fig. 1C ). To further evaluate the extent of Rab5 accumulated at the cell periphery, we measured the relative levels of Rab5 within the area located within a distance of 2-3 m of peripheral edge of the cell (this distance represents ϳ25% of the cell; supplemental Fig. 1 ). As expected, a 2-fold increase of peripheral Rab5 was associated to expression of caspase 8 (Fig. 1C) .
These observations were confirmed in parallel studies expressing GFP-tagged caspase 8 in NB7 cells (supplemental Fig. 1 ). Overall co-localization of Rab5 with early (EEA1) or late endocytic proteins (Rab7, M6PR) was not generally affected by expression of caspase 8 (supplemental Fig. 2) , confirming Rab5 as a specific target.
To extend these observations we also used A549 carcinoma cells in which endogenous caspase 8 was silenced (Fig. 1D ). In agreement with the previous results, caspase 8 expression was associated with peripheral accumulation of Rab5, whereas loss of caspase 8 promoted a more homogenous distribution throughout the cell (Fig. 1E ). The peripheral accumulation of Rab5 did not result from protein stabilization, as no significant differences in Rab5 protein levels were associated with caspase 8 expression (supplemental Fig. 3 ). Taken together, these data indicate that caspase 8 influences localization of Rab5 endosomes within the cell.
Importantly, most Rab5 (ϳ95%) was found associated to membrane fractions, as revealed by subcellular fractionation (data not shown). These observations agree with previous reports (31) . Only a slight variation in membrane-associated Rab5 was detected in caspase 8-expressing cells (93 or 97% total Rab5 Regulation by Caspase 8 DECEMBER 26, 2008 • VOLUME 283 • NUMBER 52
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Rab5 was found associated to membranes in cells lacking or expressing caspase 8, respectively). Because most Rab5 is membrane-associated regardless the caspase 8 status, it would appear that relevant changes are in subcellular distribution of membrane-associated Rab5. The possibility that caspase 8 affects Rab5 shuttling between different early endosome populations or between early endosomes and the plasma membrane is unexpected and potentially important.
Caspase 8 Alters the Targeting of Cargo from Early to Late Endosomes-Because Rab5 is involved in trafficking of cargo from the plasma membrane to early and sorting endosomes (2), we evaluated whether caspase 8-mediated re-distribution of Rab5 influenced this process by tracking the accumulation of fluid-phase HRP in early and late endosomes. Analysis of purified endosome fractions (supplemental Fig. 4 ) revealed that the accumulation of HRP in late endosomes was substantially decreased in caspase 8-expressing neuroblastoma cells compared with caspase 8-deficient controls ( Fig. 2A, left panel) . Because substantial accumulation of HRP in late endosomes is observed only after 10 -15 min of internalization (data not shown), we assayed late endosomes at 30 min internalization. Similar trends were obtained after 10 min of internalization, although variation was higher ( Fig. 2A and data not shown) . Conversely, no differences were observed in early endosomal HRP ( Fig. 2A, right panel) . Similarly, we observed an increased accumulation of HRP in late but not early endosomes from caspase 8-deficient carcinoma cells when compared with caspase 8-expressing control cells (Fig. 2B) . The overall internalization rate was independent of caspase 8 expression in both carcinoma and neuroblastoma cells (data not shown and see below), implicating caspase 8 in regulating the delivery of cargo between the early and late endosome.
To test this possibility directly we tracked the internalization and localization of two differentially sorted cargos; that is, transferrin (i.e. cargo destined for recycling) and LDL (a cargo destined for degradation). We observed no difference in uptake of transferrin or LDL nor did we observe any changes in transferrin recycling as a function of caspase 8 expression (Fig. 3A) . The distribution of internalized transferrin was similar in these cells and co-localized to the same degree with EEA1 and Rab5 regardless of caspase 8 expression (data not shown). By contrast, the intracellular distribution of internalized LDL was markedly different when caspase 8 was expressed. Among caspase 8-deficient cells, LDL was detected throughout the cell body ( Fig. 3B, upper left panel) , whereas in caspase 8-reconstituted cells a considerable retention of LDL was seen at the cell periphery, even 30 min of post-internalization ( Fig. 3B, upper  right panel) . A partial co-localization of LDL with Rab5 was observed in caspase 8-expressing or -deficient cells, but this co-localization increased when caspase 8 was present (Fig. 3, B  and C) . These data demonstrated that expression of caspase 8 influenced the localization and fate of cargo destined to late endosomes. In fact, we observed the accumulation of LDL in Rab7-positive late endosomes ( Fig. 4A ) and M6PR-positive late endosomes and lysosomes (Fig. 4B ) selectively among cells lacking caspase 8 (Fig. 4C) . Importantly, caspase 8 did not affect expression or distribution of these protein markers for late endosomes (Fig. 4 and data not shown). Taken together, these results suggest that caspase 8 regulates the movement of cargo from early (Rab5) to late (Rab7) endosome compartments.
Caspase 8 Catalytic Activity Is Not Required to Influence Rab5 Localization-Proteolytic activity is required for the induction of apoptosis by caspase 8 but is dispensable for other activities, such as the promotion of cell migration (13, 14, 16) . Both apoptosis and cell migration are dependent upon endocytic processes, and it was therefore unclear whether proteolytic activity was required for caspase 8 to regulate the Rab5mediated trafficking. Therefore, we tested a neuroblastoma cell line stably reconstituted for a catalytically inactive mutant of caspase 8 (caspase 8/C360A). Interestingly, this mutant displayed an apparent accumulation of Rab5 at the cell periphery similar to cells expressing native caspase 8 (Fig. 5A) . Moreover, the expression of catalytically inactive caspase 8 resulted in decreased accumulation of HRP tracer in late, but not early, endosomes (Fig. 5B) . Thus, the mutant recapitulated the caspase 8 phenotype indicating that caspase 8 activity is not required for regulation of Rab5-mediated endosomal targeting.
Increased Rab5 GTP Loading in Cells Expressing Caspase 8-The processes of early endosome fusion, early-to-late endosome conversion, and subcellular localization depend on proper Rab5 activation/inactivation in time and space, which is governed by cycling between GTP binding and subsequent hydrolysis to GDP (for review, see Refs. 1 and 2). We assessed 
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whether caspase 8 influenced Rab5 GTP loading using a pulldown approach with a fusion protein that selectively binds GTP-loaded Rab5 (GST-R5BD) (32). The system selectively bound "constitutively active" Rab5 mutant Rab5/Q79L (GTPase-deficient) but not the GDP binding "dominant negative" Rab5/S34N (26) mutant (Fig. 6A, left panel) . Importantly, we detected increased levels of GTP-bound Rab5 among cells expressing caspase 8 relative to cells lacking caspase 8 (Fig. 6A,  right panel) . Densitometry confirmed that GTP loading of endogenous Rab5 was significantly (ϳ2.5-fold) increased in caspase 8-expressing cells (Fig. 6B) . Similar results were seen in transient transfection systems (supplemental Fig. 5 ), leading us to conclude that caspase 8 expression influences Rab5 activity as well as localization. Rab5 Activity Is Regulated by Caspase 8 via p85␣-We next sought to evaluate the molecular mechanism by which caspase 8 could influence Rab5 GTP loading and function. Interestingly, the SH2 domains of p85␣ were recently shown to interact with a phosphorylated tyrosine (Tyr-380) located in a peptide loop between the small and large subunits of the catalytic domain of caspase 8. Interactions between SH2 domains and this tyrosine do not require caspase 8 catalytic activity (13, 16) . Moreover, p85␣ acts as a Rab-GAP, promoting Rab5 hydrolysis of GTP (8) . Therefore, we sought to determine whether p85␣ was a critical intermediate in the caspase 8-regulated Rab5 function.
We first evaluated whether caspase 8 and p85␣ interacted within our cells. Indeed, p85␣ coprecipitated with caspase 8 from cells stably (Fig. 6C ) or transiently (supplemental Fig. 5 ) expressing caspase 8. Next, we tested whether the expression of p85␣ influenced Rab5 loading. As shown for endogenous Rab5 (Fig. 6B) , caspase 8 induced an ϳ8-fold increase in GTP loading of an exogenous Rab5 reporter (Fig. 6D) . Importantly, p85␣ expression overcame the capacity of caspase 8 to promote Rab5 GTP loading ( Fig. 6D and supplemental Fig. 5 ). Therefore, we sought to evaluate whether caspase 8 and p85␣ act reciprocally to control Rab5 activity. To test this possibility we used GFP-tagged caspase 8 mutants which were catalytically inactive (C360A) or unable to interact with p85␣ (Y380F) (16) . Neuroblastoma cells stably transfected with these mutants confirmed that catalytic activity was not required for promotion of Rab5 GTP loading (Fig. 7A) . However, mutation of the SH2 binding site that disrupted p85␣ association (Y380F) abrogated the ability of caspase 8 to increase Rab5 GTP loading (Fig. 7, A-C) . The findings were extended using HEK293T cells transiently transfected with either GFP alone (control) or GFP-tagged caspase 8, caspase 8/C360A, or caspase 8/Y380F. As in the neuroblastoma cells, expression of both wild type caspase 8-GFP or caspase 8/C360A-GFP, but not caspase 8/Y380F-GFP, increased Rab5-GTP levels (supplemental Fig. 6 ). These data raised the notion that p85␣ association with caspase 8 might influence its ability to bind Rab5 and thereby promote GTP hydrolysis.
To address this, we expressed a p85␣/R274A mutant (GAPdeficient) and a p85␣/R368A/R649A double mutant (termed ⌬R) which lacked SH2-tyrosine binding activity (8) Rab5 Regulation by Caspase 8 DECEMBER 26, 2008 • VOLUME 283 • NUMBER 52 cells expressing caspase 8. Rab5 GTP loading was then measured. Although expression of wild type p85␣ suppressed Rab GTP loading, this required Rab5-GAP activity, as the p85␣/R274A mutant could not overcome the caspase 8-mediated effect. Similarly, phosphotyrosine binding activity of p85␣ was critical to overcoming caspase 8-induced GTP loading, as loss of caspase 8 binding in the p85␣/⌬R mutants permitted caspase 8-induced Rab5 GTP loading (Fig. 7D ). Based on these results, we propose a simple initial model wherein caspase 8 may increase Rab5 GTP loading by interfering with Rab5 GAP activity of p85␣ via SH2 interactions with Tyr-380 of caspase 8 (Fig. 8) .
The 
wild type, but not p85␣/R274A or p85␣/⌬R, prevented the accumulation of peripheral Rab5 in caspase 8-expressing cells (supplemental Fig. 7A, lower panels) . Conversely, expression of the Rab-GAP deficient p85␣ allows the accumulation of Rab5 in the periphery of caspase 8-negative cells (supplemental Fig.  7A, upper panels) . Finally, unlike wild type ( Fig. 1) or catalytically deficient caspase 8 (Fig. 5 ), caspase 8/Y380F did not induce accumulation of Rab5 at the cell periphery (supplemental Fig.  7B ), further supporting the requirement of p85␣ binding for this regulation.
DISCUSSION
Caspase 8 has been associated with endocytic vesicles during execution of the apoptotic pathway (10 -12) and has been implicated in endosome remodeling after a pro-apoptotic stimuli during the type II extrinsic pathway (33) . In these cases apoptosis is dependent upon caspase 8 activity. Here, we report a novel role for caspase 8 in controlling Rab5 localization, activity, and function. The presence of caspase 8 in a variety of cells was shown to modify early endosome topology; in particular, the accumulation of Rab5-positive endosomes at the cell periphery. In agreement with this we observed concurrent changes in cargo transport from early to late endosomes and found that these events were associated with caspase 8dependent increases in the levels of GTP-bound Rab5.
Our results are somewhat surprising with respect to previous reports using overexpression strategies to map Rab5 activity (34) . We did not observe formation of enlarged early endosomes by caspase 8 (despite the fact that caspase 8 increased GTP loading of Rab5). Compared with the previously reported enlargement of early endosomes by expression of the Rab/Q79L mutant (26) , the caspase 8 impact on Rab5 function was less pronounced. We could duplicate the prior reported effects by expression of Rab5/Q79L, but not Rab5/ S34N, which led to formation of enlarged early endosomes in our cells. This approach revealed a substantial increase in co-localization of Rab5 with EEA1 (data not shown). Although informative, the concern with any overexpression system is that some of the effects observed may be exaggerated relative to a cell's normal physiology. Indeed, we observed no increase of EEA1/Rab5 colocalization among cells expressing caspase 8 (supplemental Fig. 2) . Alternatively, such differences in localization may reflect the observation that caspase 8 also activates the small GTPase Rac (15). Thus, it remains possible that coordinate Rac and Rab5 activation results in peripheral retention of early endosomes, which might not be observed after simple expression of active Rab5. Nonetheless, our data are consistent with a model proposing a dynamic and reversible assembly of Rab5 domains in early endosomes with a cyclingdependent "handoff" to Rab7 (35, 36) .
In contrast to the role of caspase 8 during apoptosis, no proteolytic activity was required to modify endosomal targeting. These data differ from caspase-3, a related enzyme that has been reported to alter transport via a proteolysis-dependent mechanism (37) . Nonetheless, recent evidence supports non-apoptotic functions for caspase 8 that are independent of catalytic activity, with several studies supporting a role for caspase 8 in cell migration and invasion (13) (14) (15) (16) 22) . In fact, caspase 8 was found to be phosphorylated on tyrosine 380 in these studies. This event compromises caspase 8 activation (13). A simple mechanism by which caspase 8 expression may influence Rab5-GTP levels and endosomal maturation via its ability to bind to p85␣ is shown.
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